Job Description

Headquartered near Basel, Switzerland - a European biotech hub - Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ(TM) (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA).





We are seeking an experienced and visionary

Global Medical Affairs Lead - Insomnia

to join our Global Medical Affairs team. This role will provide strategic medical leadership across the full product lifecycle and play a pivotal role in shaping the global medical and brand strategy for our insomnia portfolio.

Key Responsibilities

Serve as a core member of the Global Medical Affairs Leadership Team and Product Lifecycle Team Lead the development and execution of the Global Medical Affairs strategy for insomnia products Manage and develop a small team of Global Medical Directors, Medical Event Manager and Medical Affairs Trainer Co-lead the global brand strategy for daridorexant (QUVIVIQ) in close collaboration with the Global Marketing Lead Communicate the medical and scientific value of assets in a compelling and credible manner to internal and external stakeholders Lead a team of content experts supporting them to deliver the + Medical and scientific communication plan including publications
+ Scientific presence at major international congresses
+ Development of scientific materials for internal training and external engagement
+ Medical content for MSL field teams and educational meetings
Chair the daridorexant Publication Working Group in partnership with the Publication Manager Define and execute Phase IIIb, Phase IV, real-world evidence, and data-mining strategies Partner closely with Global Clinical Development for all other daridorexant trials to provide medical input into study concepts and protocols; trial execution, data interpretation and reporting Contribute to the review and approval of investigator-sponsored trials, ensuring scientific integrity and compliance

Qualifications & Experience

MD 15+ years of experience in the pharmaceutical or biotech industry Extensive experience in Medical Affairs, including senior global leadership roles Proven track record in leading global medical strategy for late-stage and/or marketed products Strong track record in broad/primary care and specialist disease product commercialization Strong experience in CNS therapeutic areas, preferably insomnia, sleep medicine, neurology, or psychiatry Demonstrated leadership of cross-functional and global teams Hands-on experience with: + Publications and Congress strategy
+ Phase IIIb/IV and real-world evidence generation
+ Collaboration with Clinical Development on trial design and execution
Strategic mindset with a sense of urgency and strong execution capabilities Exceptional scientific communication and influencing skills Ability to translate complex data into compelling medical narratives Ability to inspire and lead teams effectively within an entrepreneurial, matrix and multi-cultural environment Ability to successfully engage at executive leadership level and with international key stakeholders High ethical standards and deep understanding of medical governance and compliance

Why Join Us

You will have the opportunity to shape global medical strategy for an innovative insomnia portfolio, influence late-stage development and post-approval evidence generation, and lead a highly skilled global medical team within a dynamic organization.

Work Location:

Allschwil, Switzerland

Business Area:

Global Medical Affairs

Schedule:

Fulltime

Job Type:

Permanent

Job ID

: 4690

At Idorsia, we harness the power of difference, authenticity, and inclusion to achieve business success.

We encourage all potential candidates with diverse backgrounds of race, color, religion, sexual orientation, gender identity, age, national origin, and disability to submit their job applications. All applicants will receive consideration.

We are committed to fostering respect, fairness, and equal opportunities for all job applicants and our employees.


Please be informed that if you are selected for this position, your employment will be subject to a pre-employment background screening process, of which you would be informed in greater detail in due course.


Idorsia Pharmaceuticals Ltd ("Idorsia") is committed to a fair and transparent application process. In order to avoid any conflict of interest in line with Idorsia Code of Business Conduct, which would undermine such a commitment, the applicants must disclose any personal, financial, or other outside interests interfering with the interests of Idorsia. Further, the applicant is obliged to disclose any and all relationships with close or affiliated persons, who are employees of Idorsia or are collaborating with Idorsia in any other contractual relationship.


Please note Idorsia operates a strictly controlled list of preferred recruitment partners. For those partners who have no valid, signed Master Service Agreement in place with Idorsia, all unsolicited resumes, CVs, anonymous profiles, or any other candidate details submitted through our website or to personal e-mail accounts of employees of Idorsia Pharmaceuticals (including any of its subsidiaries, affiliates, or related companies) are considered the property of Idorsia Pharmaceuticals and are not subject to payment of any form of introduction, placement or referral fees.